Bloom Energy shares are surging following the official announcement that the company will be added to the S&P 500 index as part of its quarterly rebalancing, effective September 21, 2026. The stock gained over 7 percent during the regular session in anticipation of the move and continued to climb in after-hours trading once the inclusion was confirmed. This milestone is supported by the company's strong 2026 performance, which includes record quarterly earnings and high demand for its fuel-cell technology to power artificial intelligence data centers.

Bloom Energy  ·  Updated Sep 5

Intuit is trading lower today as the stock continues to face pressure from a disappointing fiscal 2027 guidance update and a strategic reset that included a 17 percent workforce reduction. Investor sentiment is further weighed down by a looming September 8 deadline for a shareholder class action lawsuit and reports of institutional stake reductions. The primary catalyst for the ongoing decline remains a first-quarter earnings forecast that significantly missed analyst expectations, reflecting concerns over slowing growth in the TurboTax and Mailchimp segments.

Intuit  ·  Updated Sep 4

Accenture is moving higher following a reiterated Buy rating from UBS with a $275 price target, which highlighted the company's leadership in AI monetization and a new seven-year NATO contract valued at approximately €200 million. While some market participants express concern that AI automation could potentially compress billable hours in legacy consulting lines, the stock is currently supported by the company's strategic acquisition of COMWARE to expand its mid-market AI and cloud offerings. This company-specific move reflects investor optimism regarding Accenture's ability to successfully transition into a high-growth AI services provider despite broader macroeconomic uncertainty.

Accenture  ·  Updated Sep 5

Cellebrite DI shares are declining as investors digest a recent proxy filing regarding the new CEO's compensation and governance changes, alongside ongoing insider sell-to-cover transactions. The downward movement is further exacerbated by a broader technology sector selloff driven by rising Treasury yields and lingering negative sentiment following the company's significant downward revision to its full-year guidance in August. This combination of company-specific leadership transitions and macroeconomic headwinds has contributed to the stock's position as a top loser today.

Cellebrite DI  ·  Updated Sep 5

Atlassian shares are declining today primarily due to reports of competitive pressure from Anthropic's new AI feature, Cowork, which investors fear could disrupt the company's seat-based subscription model by automating complex project management tasks. Although BTIG issued a price target upgrade this morning citing the company's pricing power, the stock is facing significant downward pressure as the market reacts to potential AI-driven displacement and engages in profit-taking following a 153 percent rally over the past six months. This move is largely driven by company-specific competitive threats within the collaboration software sector and broader market concerns regarding the long-term viability of traditional software-as-a-service models in an AI-native environment.

Atlassian  ·  Updated Sep 4

HubSpot shares are rising significantly following the company's updated 2026 financial forecast, which projected revenue and earnings above Wall Street expectations due to strong adoption of its artificial intelligence agents. This positive momentum is further supported by the completion of a significant share buyback program and a broader recovery in high-growth software stocks. The move appears to be company-specific, driven by investor optimism regarding HubSpot's AI-integrated product roadmap and improved forward visibility.

HubSpot  ·  Updated Sep 5

Delek US Holdings (DK) is moving higher today following news of a significant new investment by Jupiter Topco LLC and positive market sentiment surrounding favorable regulatory decisions on small refinery exemptions. The stock's upward momentum is further supported by strong refining industry tailwinds, including elevated diesel crack spreads and the company's recently boosted throughput guidance following a profitable second quarter.

Delek US Holdings  ·  Updated Sep 5

AtriCure is moving significantly higher following a series of bullish analyst updates, most notably a price target increase to 64 dollars from Needham on September 2, 2026, driven by optimism surrounding the BoxX-NoAF clinical trial. This momentum is further supported by recent price target hikes from Piper Sandler and BTIG, as well as investor anticipation ahead of the company's scheduled presentation at the Wells Fargo Healthcare Conference on September 8. The stock's upward trajectory also reflects continued positive sentiment from a substantial second-quarter earnings beat that surpassed Wall Street expectations and pushed shares to new 52-week highs.

Atricure  ·  Updated Sep 5

Expedia Group shares are rising today following a series of positive analyst reports and a major product expansion for its vacation rental platforms. On September 4, Zacks.com identified the company as a strong growth stock, while Simply Wall St highlighted that the stock remains significantly undervalued following the global launch of 12 new partner tools for Vrbo and Escapia. This bullish sentiment is further supported by the recent introduction of global sponsored listings on Vrbo, which is expected to drive new revenue growth.

Expedia  ·  Updated Sep 5

Celanese is moving higher following the announcement of a 152 million dollar sale of an additional 19 percent stake in its Nutrinova joint venture to Mitsui and Company, a move aimed at accelerating the company's deleveraging and debt reduction efforts. The stock is also benefiting from a broad sector-wide rally in chemical manufacturers and positive market sentiment regarding its strategic expansion into advanced materials for robotic applications. These developments have led to increased institutional interest as investors reassess the company's valuation and long-term growth initiatives.

Celanese  ·  Updated Sep 5

Ventas (VTR) is moving higher today following reports of significant institutional investment, including a new 11.7 million dollar stake from Nykredit A S, which contributes to a recent trend of hedge fund accumulation. The stock also continues to benefit from positive momentum after Wells Fargo raised its price target to 104 dollars earlier this week, citing strong double-digit growth in the company's senior housing operating portfolio. This upward trend is further supported by broader sector strength in healthcare REITs as investors react to raised full-year guidance and favorable demographic tailwinds.

Ventas  ·  Updated Sep 5

Stride Inc. shares are surging today after the company reported first-quarter fiscal 2025 financial results that significantly outperformed analyst estimates for both earnings and revenue. The company posted earnings of $0.94 per share on $551.1 million in revenue, bolstered by an 18.5 percent year-over-year increase in student enrollments. This company-specific rally is further supported by management raising its full-year 2025 revenue and operating income guidance, reflecting strong demand for its digital and career learning programs.

Stride  ·  Updated Sep 5

eBay is moving significantly today as investors react to GameStop's preliminary earnings report, which revealed that its quarterly profits were largely driven by massive investment gains from its multi-billion dollar stake in the online marketplace. This positive sentiment is bolstered by eBay's recent strategic momentum in high-margin categories like fashion and collectibles, though some market data from the previous session showed a slight price decline. The move appears to be company-specific, reflecting a broader market reassessment of eBay's valuation following institutional validation and successful brand initiatives.

eBay  ·  Updated Sep 5

AXT, Inc. (AXTI) is moving significantly higher following a recent analyst upgrade to a Buy rating with an $85 price target, as investors capitalize on a sharp price correction to re-enter the semiconductor growth story. The stock is also benefiting from increased speculative volume in leveraged ETFs and positive sentiment regarding its subsidiary Tongmei’s plans for a Hong Kong listing. This move appears to be company-specific, reflecting a buy the bottom trend after the stock's recent pullback from its yearly highs.

AXT  ·  Updated Sep 5

General Mills (GIS) is moving higher today following a positive analyst note from Jefferies that highlighted the company's $3 billion cost-saving initiative and improved execution as key drivers for future profitability. The stock is also benefiting from the successful completion of the sale of its Brazil business to 3corações and the announcement of a new product collaboration wave across core brands like Annie's and Cinnamon Toast Crunch to energize retail sales. This upward momentum represents a significant rebound from sector-wide pressure earlier in the week, reflecting improved investor sentiment toward the company's portfolio reshaping strategy.

General Mills  ·  Updated Sep 5

Beam Therapeutics is moving significantly higher today due to investor anticipation surrounding the upcoming late-breaking oral presentation of updated BEAM-302 clinical data at the European Respiratory Society (ERS) Congress 2026. This positive momentum is further supported by a recent analyst upgrade and a broader rally in the biotech sector, characterized by increased institutional interest and the XBI small-cap biotech index approaching all-time highs. The move appears to be a combination of company-specific clinical catalysts and favorable sector-wide dynamics.

Beam Therapeutics  ·  Updated Sep 5

Progressive Corporation (PGR) is moving higher today following a rebound in market sentiment driven by a valuation narrative suggesting the stock is approximately 3% undervalued with a fair value target of $230.71. This upward momentum is further supported by recent reports of institutional buying, including a new share acquisition by Nykredit A S, which has offset news of recent insider selling by the company's CEO. The stock's gains reflect its position as a top gainer in the insurance sector as investors focus on its superior data analytics and potential for continued market share growth.

Progressive  ·  Updated Sep 5

The FCC asked a court to dismiss Disney’s lawsuit challenging an early review of licenses for its eight ABC stations, saying the case could hinder its investigation into allegations of unlawful discrimination.

Walt Disney  ·  Updated Sep 4

ServiceTitan is experiencing a significant decline as investors engage in profit-taking and reverse a momentum-driven rally that saw the stock gain 48 percent over the last six months. The downward pressure stems from fading anticipation and a reassessment of the company's valuation ahead of its fiscal second-quarter 2027 earnings report scheduled for September 8, 2026. This pullback appears to be company-specific as it occurs despite broader strength in the software sector.

ServiceTitan, Inc. Class A  ·  Updated Sep 5

Edgewise Therapeutics is surging today following the announcement of positive top-line results from its Phase 2 CIRRUS-HCM trial in patients with obstructive hypertrophic cardiomyopathy and a Phase 1 trial in healthy subjects. The data for its lead cardiac candidate, EDG-7500, demonstrated significant and rapid reductions in left ventricular outflow tract gradients while remaining well-tolerated, reinforcing the drug's potential as a primary treatment for serious cardiac conditions. This significant upward movement is a company-specific reaction to these successful clinical milestones and is supported by unusually high trading volume.

Edgewise Therapeutics  ·  Updated Sep 5

Pharvaris PHVS is moving significantly higher today following the presentation of positive clinical and translational data for its lead candidate, deucrictibant, at the Bradykinin Symposium 2026. The data highlighted the drug's injectable-like efficacy and placebo-like tolerability, including Phase 3 results showing rapid symptom relief and Phase 2 extension data demonstrating a sustained 93 percent reduction in hereditary angioedema attack rates. This clinical momentum, coupled with the recent submission of a New Drug Application for the treatment's on-demand formulation, has driven strong investor sentiment and high trading volume.

Pharvaris  ·  Updated Sep 5

Regeneron Pharmaceuticals is moving significantly higher as investors engage in dip-buying following a sharp sell-off earlier in the week triggered by a Phase 3 trial failure for its melanoma treatment, fianlimab. This recovery is underpinned by positive sentiment surrounding the recent FDA approval of Pasatru for a rare genetic disorder and the company's strong second-quarter earnings performance, which exceeded analyst expectations. The stock's gains represent a rebound from the volatility caused by the trial results and subsequent litigation alerts.

Regeneron  ·  Updated Sep 5

nCino's stock is declining significantly today as investors react to the company's disappointing third-quarter revenue guidance, which fell short of analyst expectations despite a second-quarter earnings beat. The downward movement is further fueled by concerns over slowing subscription growth and persistent headwinds in the U.S. mortgage sector, which have overshadowed a recently authorized 100 million dollar share repurchase program. This move appears to be company-specific, reflecting a correction following a brief post-earnings rally in the broader software sector.

nCino  ·  Updated Sep 4

Extreme Networks is moving higher today likely due to positive investor sentiment following the company's recent appointment of Deloitte as its new independent auditor and its ongoing participation in several major investor conferences throughout September 2026. The stock is also experiencing a technical rebound after testing key support levels earlier in the week, bolstered by unusual options activity that suggests market anticipation of a significant price move. This upward momentum appears to be company-specific, driven by increased institutional confidence in the company's financial reporting and its strategic focus on AI-powered networking platforms.

Extreme Networks  ·  Updated Sep 5

Onto Innovation is moving significantly higher following a surge in investor interest tied to its critical role in the AI semiconductor supply chain, specifically its ability to address yield bottlenecks in advanced packaging. The stock's upward momentum is further supported by positive analyst sentiment regarding upward earnings estimate revisions and a technical rebound from recent support levels as the company benefits from sustained capital expenditure in AI and data center infrastructure.

Onto Innovation  ·  Updated Sep 5

SSR Mining Inc. (SSRM) is experiencing a significant price decline today due to a broad sell-off across the gold mining sector, driven by a sharp drop in bullion prices to a two-week low. This downward momentum is primarily attributed to hawkish commentary from the Federal Reserve, which has intensified market expectations for an interest rate hike in September and diminished the safe-haven appeal of precious metals.

SSR Mining  ·  Updated Sep 5

Vertex Pharmaceuticals is trading higher following the successful completion of its 10 billion dollar acquisition of Crinetics Pharmaceuticals, a strategic move that establishes endocrinology as a new core therapeutic pillar for the company. The stock is also benefiting from its recent addition to the Goldman Sachs conviction list and an FDA label expansion for its gene therapy, Casgevy, to include patients as young as two years old. These company-specific catalysts have bolstered investor confidence in the company's long-term growth and pipeline diversification beyond its core cystic fibrosis franchise.

Vertex Pharmaceuticals  ·  Updated Sep 5

Novartis (NVS) is trading higher primarily due to positive Phase III trial results for remibrutinib, which demonstrated clinical superiority in treating relapsing multiple sclerosis by significantly reducing annualized relapse rates. This upward momentum is further supported by a 3.2 billion dollar licensing deal with Alteogen to enhance its drug-delivery portfolio and a favorable UK court ruling protecting the patent for its blockbuster drug Entresto. These company-specific catalysts have largely overshadowed a recent pause in the company's experimental CAR-T program and a late-stage trial failure for its cardiovascular drug pelacarsen.

Novartis  ·  Updated Sep 5

KKR agreed to make a minority investment in Avisena Healthcare. The funds will support expanded multispecialty services at its Shah Alam hospitals and the development of new hospitals in Malaysia’s Klang Valley, subject to closing conditions.

KKR & Co  ·  Updated Sep 4

AbbVie is moving higher following the announcement of positive topline results from its Phase 3 CERVINO trial for etentamig, which met dual primary endpoints in treating multiple myeloma. The stock is also supported by the completion of its 10.9 billion dollar acquisition of Apogee Therapeutics and a raised 2026 revenue guidance of 67.6 billion dollars. This company-specific rally reflects investor optimism regarding the expansion of AbbVie's immunology and oncology pipelines as it successfully navigates biosimilar competition for Humira.

AbbVie  ·  Updated Sep 5

Woori Financial Group (WF) is experiencing significant upward momentum following reports that Chairman Lim Jong-ryong and 56 group executives purchased treasury shares, signaling strong internal confidence in the company's valuation and future performance. This insider buying activity coincides with the announcement of a ₩90 trillion (approximately $66.4 billion) productive and inclusive finance initiative aimed at driving growth through subsidiary synergies and enhanced non-bank profitability. While some market reports indicated a price decline on the previous trading day due to overvaluation concerns, the current gain appears driven by this collective insider support and the company's strategic expansion into securities and insurance sectors.

Woori Finance Holdings Co  ·  Updated Sep 5

Forgent Power Solutions (FPS) is rising today following a positive mention by Jim Cramer on CNBC’s Lightning Round and reports of significant institutional buying, including a newly disclosed stake by B. Metzler seel. Sohn & Co. AG. The stock is also benefiting from bullish sentiment surrounding its role in AI-driven data center infrastructure and power grid electrification ahead of its upcoming earnings release on September 15. This upward movement reflects a company-specific rebound driven by strong market reception to its growth narrative in the electrical distribution sector.

Forgent Power Solutions, Inc. Class A  ·  Updated Sep 4

Stryker is moving higher today following the announcement of a significant technological milestone, having completed the first hip arthroscopy using its FDA-authorized SportSuite Vision software on Apple Vision Pro. This advancement in digital surgery, coupled with the recent definitive agreement to acquire ZuriMED to expand its shoulder care portfolio, has bolstered investor confidence in the company's innovation pipeline. The stock's gains are also supported by broader market optimism as reduced concerns over interest rate hikes lifted the healthcare sector and major indexes.

Stryker  ·  Updated Sep 4

MGIC Investment Corporation (MTG) is moving significantly higher today as investors react to the company's aggressive capital return strategy, which includes a recently authorized $750 million share repurchase program and a dividend increase to $0.17 per share. Market sentiment is further bolstered by recent analyst reports and institutional filings highlighting the stock as undervalued relative to its peers in the mortgage insurance sector, leading to increased value-oriented buying. The upward momentum is also supported by a broader trend of institutional accumulation, including a notable acquisition of shares by The Manufacturers Life Insurance Company reported earlier this week.

MGIC Investment  ·  Updated Sep 5

Aon plc shares are rising today as the stock rebounds from a sharp sell-off following its 17 billion dollar acquisition of USI Insurance Services, supported by a regulatory filing disclosing that Director Lester Knight purchased approximately 6.5 million dollars worth of shares. Positive sentiment is further driven by the launch of a new underwriting analytics platform and a company report highlighting record global reinsurance capital of 800 billion dollars, which signals a favorable environment for strategic growth. This upward movement reflects a shift in market focus toward the company's long-term expansion potential and insider confidence.

Aon  ·  Updated Sep 4

Becton, Dickinson and Company is moving significantly higher today due to continued investor optimism following a recent guidance raise and robust demand for its high-margin GLP-1 drug delivery systems and Alaris infusion pumps. The stock is also benefiting from its strategic transformation into a pure-play medical technology company and a price target increase to $200 by Bank of America. This upward movement persists despite conflicting reports of a process error that excluded the company from a significant UK procurement framework.

Becton Dickinson  ·  Updated Sep 5

McKesson is trading significantly higher today as investors react to reports of substantial new institutional positions from firms such as Barlow Wealth Partners and Nykredit A S. This buying activity reinforces positive market sentiment following the company's recent first-quarter earnings beat, raised full-year guidance, and its $2.25 billion acquisition of Precision Medicine Group. The upward move suggests that these strong growth catalysts and a significant decrease in short interest are currently overshadowing recent concerns regarding a cybersecurity disclosure.

McKesson  ·  Updated Sep 4

Talos Energy is trading significantly lower today following a regulatory filing that disclosed a 120,000-share sale by Executive Vice President William S. Moss III, which has intensified market concerns regarding a recent trend of insider selling. The downward movement is further compounded by lingering investor caution over the company's 2026 production outlook and the potential for share dilution following a recent shelf registration for future stock issuance. This decline appears to be primarily company-specific, though it occurs amid a period of broader volatility for offshore exploration and production firms.

Talos Energy  ·  Updated Sep 4

PepsiCo is moving lower today primarily because the stock is trading ex-dividend for its 1.48 dollar quarterly payout, a technical adjustment that typically reduces the share price by the amount of the dividend. The decline is further intensified by broader market volatility following a recent jobs report and persistent investor concerns regarding stalled volume growth in the company's North American snack and beverage divisions. This combination of a scheduled dividend adjustment and macroeconomic headwinds has positioned the stock as one of the day's notable underperformers.

PepsiCo  ·  Updated Sep 4

Grindr shares are climbing significantly following the resolution of a major UK group action lawsuit regarding historical data practices, a move that eliminates a long-standing legal uncertainty and defines the company's future cash obligations. This positive momentum is further supported by the announcement of the company's participation in an upcoming major technology conference and the lingering impact of recently raised full-year financial guidance.

Grindr  ·  Updated Sep 5

Neutron Holdings (LIME) is experiencing a significant price decline as the stock continues a multi-day pullback from its recent post-earnings highs. The downward movement is primarily driven by profit-taking following a substantial rally and news of insider selling by the company’s CEO and a director. This correction follows a period of consolidation after the company’s July IPO and a blowout second-quarter earnings report.

Neutron Holdings, Inc.  ·  Updated Sep 5

Devon Energy is moving significantly higher today following a major analyst upgrade from Seaport Research Partners to a Strong Buy rating with a 65 dollar price target, reflecting confidence in the company's Permian Basin assets and capital efficiency. The stock's upward momentum is further supported by a sector-wide rally in oil prices triggered by escalating military tensions and reported strikes between the United States and Iran in the Strait of Hormuz. This combination of company-specific analyst optimism and heightened geopolitical supply risks has positioned the stock as a top gainer in the energy sector.

Devon Energy  ·  Updated Sep 5

Arthur J. Gallagher & Co. shares are rising as investors purchase the stock ahead of the September 8 ex-dividend date to secure the recently declared 0.70 dollar quarterly dividend. The upward momentum is further supported by the company's announcement of a quarterly management meeting scheduled for September 23 and continued positive sentiment from analysts regarding the firm's organic growth outlook. This movement appears to be company-specific, driven by dividend capture and a favorable reception to the company's upcoming investor engagement.

Arthur J Gallagher & Co  ·  Updated Sep 5

HCA Healthcare is moving higher today following a quarterly earnings report that narrowly exceeded analyst expectations and the declaration of a $0.78 per share dividend. The stock is also benefiting from positive market sentiment surrounding the company's announcement of strategic corporate layoffs designed to mitigate rising hospital cost pressures and protect long-term margins. This upward momentum suggests investors are prioritizing HCA's operational resilience and capital return programs over previous concerns regarding insurance coverage shifts and payer mix.

HCA Healthcare  ·  Updated Sep 5

Steel Dynamics is moving significantly today due to a sector-wide cost-driven rebound and optimistic expectations for the Golden September peak season, which are driving finished steel prices higher. The stock is also supported by strong domestic pricing power and escalating trade tensions with Canada that favor U.S. producers, though some market reports provide conflicting data indicating the stock is trading lower. This movement appears to be driven by broader sector dynamics and favorable domestic trade policy rather than company-specific announcements.

Steel Dynamics  ·  Updated Sep 4

Vishay Intertechnology is moving higher following a positive initiation from Truist Securities, which issued a Buy rating and a $42 price target, citing significant upside potential from the company's structural growth initiatives and cultural evolution. This momentum is further supported by the recent launch of several high-performance electronic components, including new thin-film resistors and automotive-grade chokes designed for high-growth sectors like e-mobility and industrial automation. The upward trend reflects strong market sentiment regarding the company's long-term earnings outlook and its ability to capture demand in the early stages of a semiconductor upcycle.

Vishay Intertechnology  ·  Updated Sep 5

UFP Technologies (UFPT) is moving significantly higher today following news of a substantial new institutional investment by Legal and General Group Plc, which reported a new position valued at approximately 4.78 million dollars. This builds on the stock's strong momentum from record-breaking second-quarter 2026 financial results and management's recently reaffirmed long-term growth targets of 12 percent to 18 percent within the MedTech sector. The move appears to be company-specific but is further supported by a broader market rotation into high-performing small-cap stocks.

Ufp Technologies  ·  Updated Sep 4

Dorian LPG ordered three $345 million dual-fuel Panamax VLGCs from Hanwha Ocean for 2030 delivery, supporting fleet renewal and efficiency. It also secured a seven-year $368.4 million credit facility to consolidate debt, reduce financing costs and improve flexibility.

Dorian LPG  ·  Updated Sep 4

NewAmsterdam Pharma (NAMS) is moving significantly higher following the presentation of Phase 3 clinical data for its lead cardiovascular candidate, obicetrapib, at the European Society of Cardiology (ESC) Congress 2026. The stock's upward momentum is further supported by positive market sentiment following a recent favorable opinion from the CHMP in Europe and anticipation surrounding the upcoming interim analysis of the PREVAIL cardiovascular outcomes trial.

NewAmsterdam Pharma Company  ·  Updated Sep 5

Ionis Pharmaceuticals is trading significantly lower today following the announcement that the Phase 3 Lp(a)HORIZON trial for pelacarsen, a cardiovascular drug partnered with Novartis, failed to meet its primary endpoint of reducing major cardiovascular events. Although the therapy successfully lowered lipoprotein(a) levels, the lack of clinical benefit has triggered a sharp sell-off and raised broader concerns about the efficacy of the entire Lp(a)-lowering drug class. This clinical setback significantly impacts the company's long-term growth outlook, overshadowing the recent FDA approval of its neurology drug, Zanvastro.

Ionis Pharmaceuticals  ·  Updated Sep 5

Group 1 Automotive shares are rising significantly following reports of substantial insider buying by major shareholder Conifer Management, which recently acquired 26,561 shares at an average price of 276.03 dollars. This company-specific move is further bolstered by new institutional positions and a technical rebound as the stock recovers from a recent 52-week low. The rally suggests a shift in investor sentiment as the market prioritizes aggressive insider activity and strategic dealership acquisitions over previous quarterly earnings misses.

Group 1 Automotive  ·  Updated Sep 5

NRG Energy shares are rising significantly as investors refocus on the company's strategic data-center growth plans in Texas and its potential to capitalize on the increasing power demand from artificial intelligence. This positive momentum follows a period of decline after a second-quarter earnings miss, with the current rally supported by the company's reaffirmed 2026 financial guidance and commitment to share buybacks. The move appears to be company-specific as the market reassesses NRG's valuation following its recent drop to a 52-week low.

NRG Energy  ·  Updated Sep 5

Royalty Pharma is trading lower today following the announcement that the Phase 3 HORIZON trial for pelacarsen, a cardiovascular drug in which the company held a significant royalty interest, failed to meet its primary endpoint. This clinical setback has triggered profit-taking after the stock recently reached a 52-week high, with the move further compounded by broader market volatility and concerns regarding the loss of potential upside from the company's 500 million dollar investment in the program. The decline is primarily company-specific, reflecting investor reassessment of future royalty receipts following the trial failure.

Royalty Pharma  ·  Updated Sep 5

Amgen shares are falling significantly today following a report from analysts at Cantor Fitzgerald that highlighted safety concerns regarding the company's experimental obesity drug, MariTide. The report pointed to Phase 1 clinical data showing a loss in bone mineral density among some patients, which investors fear could hinder its competitive position against rival treatments from Eli Lilly and Novo Nordisk. This company-specific news has overshadowed broader market trends and led to a sharp decline in the stock price.

Amgen  ·  Updated Sep 5

Vicor Corporation (VICR) shares are surging today following the announcement of a new $150 million share repurchase program and a regulatory filing revealing that JPMorgan Chase & Co. has established a 4.0% passive stake in the company. This positive momentum is further driven by strong market sentiment surrounding the company's Gen 5 vertical power delivery products, which are positioned to meet the high-density power demands of the expanding AI infrastructure sector. The gains come despite some analyst notes suggesting the stock is currently overvalued relative to its intrinsic value and reports of significant insider selling over the past year.

Vicor  ·  Updated Sep 5

Cheniere Energy shares are declining significantly after the company was excluded from the S&P 500 index in the latest rebalancing, a decision that disappointed investors who had widely anticipated its inclusion. This downward momentum is further compounded by a recent quarterly report detailing a multi-billion dollar net loss driven by non-cash derivative accounting adjustments linked to geopolitical volatility and shifting global gas prices. The move is primarily company-specific, reflecting a sharp reversal in sentiment as traders unwind positions previously built on index-inclusion expectations.

Cheniere Energy  ·  Updated Sep 5

Allegro MicroSystems is moving higher primarily due to StoneX reiterating a Buy rating on September 4, 2026, which highlighted the stock's attractive valuation at approximately 17 times target earnings per share. This positive momentum is further supported by recent regulatory filings revealing significant institutional share purchases by major firms, including the Canada Pension Plan Investment Board and Man Group plc. The gains reflect a recovery in sentiment as analysts point to strong long-term demand for power semiconductors in AI data centers and the automotive sector.

Allegro MicroSystems  ·  Updated Sep 5

MACOM Technology Solutions is moving significantly lower today as a hawkish Federal Reserve outlook and a spike in the 10-year Treasury yield above 4.75 percent trigger a broad sell-off in high-valuation semiconductor stocks. While the stock saw a brief recovery on September 4, today's decline reflects a sharp reversal driven by profit-taking and persistent concerns that the company remains significantly overvalued relative to its intrinsic fair value. This downward momentum is further compounded by a risk-off market sentiment following reports of substantial insider selling over the past year.

MACOM Technology Solutions Holdings  ·  Updated Sep 5

Honeywell Aerospace is declining significantly due to a broad market selloff triggered by surging Treasury yields and heightened geopolitical tensions in the Middle East, which have weighed heavily on the industrial sector. The downward move is exacerbated by company-specific pressure from a 2.04 million dollar settlement with the Justice Department over False Claims Act allegations and continued investor concern following a recent reduction in the company's 2026 growth guidance. This combination of macroeconomic headwinds and a cautious operational outlook has positioned the stock as a top loser in recent trading sessions.

Honeywell Aerospace  ·  Updated Sep 5

LifeStance Health Group (LFST) is trading significantly lower following reports of substantial share sales by major stakeholders, most notably a divestment of over 13.6 million shares by major shareholder TPG GP A, LLC. Additionally, recent regulatory filings revealed that the company's Chief Technology Officer sold a portion of his holdings, further contributing to negative market sentiment and increased selling pressure. This company-specific movement suggests that investors are reacting to large-scale liquidations by key institutional and internal insiders despite the company's recent positive earnings performance.

Lifestance Health Group  ·  Updated Sep 5

Powell Industries is moving significantly lower today as part of a continuous "de-rating" driven by an execution gap between its record $2.4 billion backlog and its slower-than-expected revenue conversion. The stock has faced persistent pressure since missing both revenue and earnings estimates for the third consecutive quarter in its August fiscal results, leading to investor skepticism regarding the company's ability to scale production despite robust demand from the data center and utility sectors. This downward momentum is further exacerbated by broader sector-wide selling in high-beta industrial stocks amid rising bond yields and valuation concerns.

Powell Industries  ·  Updated Sep 5

Star Bulk Carriers is moving lower today following the company's announcement of a parallel listing on Euronext Athens and a concurrent equity offering of up to 4,400,000 new common shares. The stock's decline is primarily driven by investor concerns regarding shareholder dilution and the offering's maximum price of 25.50 Euros, which represents a discount to recent trading levels. This company-specific development is the primary catalyst for the downward movement, occurring as the stock trades near its 52-week high.

Star Bulk Carriers  ·  Updated Sep 5

Generac Holdings Inc. shares are declining significantly as part of a broader sector-wide rotation out of power technology and AI infrastructure stocks following hawkish signals from the Federal Reserve regarding potential interest rate hikes. This downward pressure is compounded by investor caution over a softening residential growth outlook and recent insider selling activity by the company's top executives. The move appears to be driven by a combination of macroeconomic sentiment and a recalibration of growth expectations for the residential segment.

Generac Holdings  ·  Updated Sep 5

James Hardie Industries is falling significantly today following the release of its full-year financial results, which included a fiscal 2025 earnings and volume guidance that missed analyst expectations. Despite reporting record profits for the previous year, the company's cautious outlook for the North American housing market and projected increases in marketing and administrative costs have triggered a sharp sell-off. This downward movement is primarily company-specific, reflecting investor concerns over future growth and margin pressure in its largest market.

James Hardie Industries PLC  ·  Updated Sep 5

Twilio's stock is moving lower primarily due to valuation concerns, with recent market analysis suggesting the shares may be overvalued following a significant price surge in August. This downward momentum is further fueled by investor unease regarding substantial insider selling, as reports indicate the company's CEO and CFO have sold approximately $334 million in stock over the past 90 days. The decline reflects a correction in sentiment as the market recalibrates the stock's price relative to its long-term growth outlook and executive activity.

Twilio  ·  Updated Sep 5

State Street is moving higher today following the record-breaking launch of its SPDR UC Investments 90/10 Endowment Strategy Index ETF, which debuted with a $2.50 billion anchor investment. The stock is also benefiting from broader financial sector strength after the August jobs report significantly exceeded consensus estimates, reinforcing investor confidence in the company's recently upgraded 2026 net interest income and fee revenue guidance.

State Street  ·  Updated Sep 4

Gates Industrial Corporation plc (GTES) is moving significantly lower today, primarily driven by broader macroeconomic concerns following weaker-than-expected U.S. industrial production data that has pressured the macro-sensitive industrials sector. The decline also reflects a period of consolidation as investors rotate out of engineered components stocks after recent earnings-related gains, coupled with technical sell signals and concerns that the stock is currently overvalued. This movement appears to be part of a wider sector trend and a reaction to soft manufacturing demand rather than a result of specific company-specific news.

Gates Industrial  ·  Updated Sep 5

Liberty Energy (LBRT) is moving significantly lower today primarily due to the stock trading ex-dividend following its previously announced quarterly cash dividend of $0.09 per share. While the dividend adjustment accounts for a portion of the decline, the stock remains under broader pressure from investor concerns regarding a nearly 50% increase in the company's 2026 capital expenditure budget intended to fund its long-term power generation initiatives. This shift toward high-capital investment in data center power infrastructure has weighed on near-term cash flow sentiment, leading to continued volatility and underperformance relative to the broader energy sector.

Liberty Energy  ·  Updated Sep 5

Cummins Inc. (CMI) is moving lower primarily due to a broad selloff in the industrials and cyclical sectors triggered by surging oil prices, which has raised concerns regarding increased manufacturing costs and margin compression. This downward pressure is further compounded by residual negative sentiment from a second-quarter earnings miss and significant outflows from momentum-focused ETFs that include the stock. The movement appears to be driven by a combination of sector-wide dynamics and company-specific concerns regarding near-term profitability.

Cummins  ·  Updated Sep 5

AtaiBeckley shares are declining significantly today as investors de-risk ahead of the company's final shareholder vote on the Eli Lilly acquisition scheduled for Tuesday, September 8. The downward pressure is likely intensified by the stock's upcoming removal from several global indices on September 9 and a broader market retreat following the latest U.S. employment data. This sell-off reflects a narrowing of the merger arbitrage spread and investor caution before the long holiday weekend and the deal's expected completion.

Atai Beckley N.V.  ·  Updated Sep 4

Astera Labs is trading significantly higher today as investors refocus on the company's strong fundamental growth and triple-digit revenue expansion following a recent market correction. The upward momentum is primarily driven by the accelerated volume production of its Scorpio X-Series AI fabric switches and bullish third-quarter guidance, which has prompted several analysts to raise their price targets. Market sentiment is further supported by anticipation of the company's upcoming participation in a major global technology conference.

Astera Labs, Inc.  ·  Updated Sep 5

Sunoco LP is moving significantly lower today as the stock continues a downward trend following a 3.2 percent decline on September 3, 2026, and news that Van ECK Associates Corp significantly reduced its position in the company by over 51 percent. The downward pressure is further attributed to a broader market rotation where defensive energy units have underperformed relative to a rally in the technology and financial sectors following signals of a potential pause in interest rate hikes. This move appears to be driven by institutional selling and shifting market sentiment rather than specific negative earnings news, as the company recently raised its full-year outlook.

Sunoco  ·  Updated Sep 5

Mattel shares are declining significantly following a disappointing 2026 profit outlook and reports of a major holiday-quarter miss that triggered a sharp sell-off earlier in the week. The downward momentum is further pressured by concerns over a second consecutive year of margin contraction and recent executive stock sales, reflecting broader investor caution regarding slowing consumer discretionary spending in the toy industry.

Mattel  ·  Updated Sep 5

Veracyte is trading lower today primarily due to a price target reduction from Canaccord Genuity, which lowered its estimate to $50 from $60 citing lower long-term revenue projections. This downward movement is further exacerbated by recent reports of insider selling and investor concerns that the company’s forecasted growth rate will significantly lag behind the broader biotechnology industry average.

Veracyte  ·  Updated Sep 5

CNH Industrial is moving significantly lower today as the stock undergoes a sharp correction following a 21 percent five-day rally that pushed shares into overvalued territory relative to their intrinsic fair value. The downward pressure is exacerbated by investor concerns over operational execution risks following a leadership transition, specifically the recent retirement of the Agriculture Chief Commercial Officer and the impending departure of the Chief Technology Officer. This reversal reflects a shift in market sentiment as traders lock in profits amidst a broader cyclical downturn in global farm equipment demand and persistent margin pressures.

CNH Industrial  ·  Updated Sep 5

Banco BBVA Argentina is declining significantly today as investors continue to react to the company's second-quarter 2026 earnings report, which featured a substantial 17.45% revenue miss and an earnings-per-share shortfall relative to analyst estimates. The downward pressure has been exacerbated by a recent analyst downgrade to a Hold rating and technical indicators signaling a bearish trend following the earnings announcement. This movement reflects broader market caution regarding the bank's performance in Argentina's complex inflationary environment despite some sequential improvements in its net income.

Banco BBVA Argentina  ·  Updated Sep 5

Sinda Ltd. (SIND) appears to be moving lower today primarily due to broader market pressure following a "hot" August jobs report released on September 4, 2026, which showed stronger-than-expected payroll growth and led to a sharp increase in Treasury yields and interest rate hike expectations. While the company recently received a $2.40 million investment from Bornite Capital Management and reported operational progress at its Don Diego silver project, the shift in macroeconomic sentiment toward a more hawkish Federal Reserve has weighed on speculative mining and exploration stocks. Additionally, the stock may be experiencing a "September effect" pullback as investors engage in seasonal profit-taking following its significant gains since its June 2026 initial public offering.

Sinda Limited  ·  Updated Sep 5

Ingevity Corporation (NGVT) is moving significantly lower today, likely pressured by a recent financial analysis highlighting a major risk regarding the company's debt coverage and overall financial position. This concern follows a substantial litigation settlement payment in the previous quarter that negatively impacted operating cash flow, contributing to a downward trend in the stock over the past month. Additionally, broader market uncertainty ahead of the U.S. jobs report has further weighed on investor sentiment, making the stock one of the day's top losers.

Ingevity  ·  Updated Sep 5

Iron Mountain is experiencing a significant decline today primarily due to broader market pressure on rate-sensitive REITs as rising Treasury yields and a hawkish Federal Reserve stance weigh on the sector. Additionally, investor sentiment has been dampened by recent reports of substantial insider selling, including a multi-million dollar stock sale by CEO William Meaney and other top executives earlier this week. These macroeconomic headwinds and insider dispositions have overshadowed recent company announcements regarding international expansion and digital partnerships.

Iron Mountain  ·  Updated Sep 5

Ocular Therapeutix (OCUL) is experiencing a significant decline today following a technical downgrade to a "Hold/Accumulate" rating and growing investor concerns regarding the financial implications of its accelerated regulatory strategy. Recent reports highlighted that while the company has established a faster path to FDA approval for its wet AMD treatment, AXPAXLI, this transition is accompanied by rising operational costs and a continued lack of profitability. This downward momentum reflects a cautious market sentiment as investors weigh the company's clinical progress against its increasing cash burn and long-term execution risks.

Ocular Therapeutix  ·  Updated Sep 4

Medtronic shares are declining today as the stock faces a sell-the-news reaction following a strong first-quarter fiscal 2027 earnings report and a 26 percent rally since May. Despite the company beating analyst estimates and raising its full-year guidance, the downward movement is being driven by profit-taking and a contrarian sell signal in the options market. Additionally, investor sentiment has been tempered by a new 700 million dollar acquisition in the robotic surgery sector, which some analysts view as a high-stakes bet on the future of its surgical platforms.

Medtronic  ·  Updated Sep 5

Teekay Tankers is moving lower today primarily due to reports of softening tanker rates and significant logistics disruptions, including a nationwide Dutch port strike and severe typhoon activity in East Asia causing vessel delays. This downward pressure is compounded by sector-wide profit-taking after shipping stocks reached decade-plus highs earlier in the week, despite conflicting reports from late August regarding whether the company's most recent quarterly revenue beat or missed analyst expectations. The move is largely driven by these broader maritime sector dynamics and a cautious outlook on near-term freight rate stability.

Teekay Tankers  ·  Updated Sep 5

Northern Oil and Gas (NOG) is moving lower today primarily due to broader market concerns regarding persistent inflation and rising interest rate expectations following an August jobs report that significantly exceeded analyst forecasts. Despite a sharp rally in crude oil prices driven by intensified conflict in the Middle East, the company's high leverage and extensive commodity price hedging program appear to be weighing on investor sentiment, as these factors limit its ability to fully capitalize on rising energy prices while increasing potential refinancing costs. Additionally, some market volatility may be attributed to confusion with Nostrum Oil & Gas (also ticker NOG), which finalized a significant debt restructuring and tender offer effective today.

Northern Oil And Gas  ·  Updated Sep 4

GE Aerospace shares are declining today as the stock faces significant profit-taking and a cooling of investor sentiment following a period of substantial outperformance. Despite the recent announcement of a 2.87 billion dollar Navy contract, the downward movement is primarily driven by analyst reports suggesting the stock has reached a premium valuation and a broader pullback within the aerospace and defense sector. This move reflects a market-driven correction as investors rotate out of high-flying industrial names amid shifting sector dynamics.

GE Aerospace  ·  Updated Sep 5

Mizuho says investor expectations are divided ahead of Alkermes’ ALKS-7290 Phase 1b ADHD trial results expected this month. Nearly half expect improvement over placebo, while most estimate $3–$6 per share in value from the drug.

Alkermes  ·  Updated Sep 4

Wells Fargo (WFC) shares are declining today primarily due to a combination of macroeconomic pressures and sector-specific regulatory concerns. Stronger-than-expected August employment data, showing 162,000 jobs added, has intensified market expectations for a Federal Reserve interest rate hike on September 16, triggering a broader sell-off in the financial sector. Additionally, the stock is facing pressure from reports that rising regulatory capital buffers may tighten excess capital at large U.S. banks, alongside market speculation identifying Wells Fargo as a likely acquirer of Regions Financial, a move that typically weighs on the potential acquirer's share price.

Wells Fargo  ·  Updated Sep 5

Harmony Gold Mining (HMY) is rising today due to a significant rally across the gold mining sector, fueled by bullion prices holding near record highs and positive analyst sentiment regarding a broader metals surge. The stock's momentum is also bolstered by the continued market digestion of the company's recent record-breaking annual financial results and its strategic expansion into copper production. This upward trend reflects a combination of strong macroeconomic tailwinds for precious metals and robust company-specific operational performance.

Harmony Gold Mining  ·  Updated Sep 4

Corcept Therapeutics (CORT) is moving significantly higher due to sustained momentum following a strong second-quarter earnings beat and a substantial upward revision of its 2026 revenue guidance to a range of $1.1 billion to $1.2 billion. Investor sentiment is further bolstered by high anticipation for the upcoming December 17, 2026, PDUFA date for relacorilant in Cushing’s syndrome and a pending NDA for its ovarian cancer indication. This upward trend is supported by recent analyst price target increases to as high as $165, reflecting confidence in the company’s expanding oncology and endocrinology pipeline.

Corcept Therapeutics  ·  Updated Sep 5

POSCO Holdings is declining today despite recent analyst upgrades, likely due to technical profit-taking after the stock failed to hold its position above the 200-day moving average reached during the previous session. Market sentiment is also being weighed down by previously disclosed operational challenges, including a temporary production slowdown at the company's Argentina lithium facilities for equipment repairs during the current third quarter. No major company-specific news has been verified in the past 24 hours, indicating the move is primarily driven by technical resistance and broader sector dynamics.

POSCO  ·  Updated Sep 4

Appian shares are declining significantly due to broader market pressure following a stronger-than-expected August jobs report, which has reignited investor fears that the Federal Reserve will maintain elevated interest rates. This macroeconomic headwind, combined with rising Treasury yields and lingering geopolitical tensions in the Middle East, has disproportionately impacted high-multiple software stocks despite a lack of negative company-specific news. The downward movement also follows a period of cautious sentiment linked to recent insider selling activity and a general risk-off environment across the technology sector.

Appian  ·  Updated Sep 5

Celcuity Inc. shares are declining today as the stock continues to face downward pressure from profit-taking following its late-August supplemental New Drug Application submission for REVTORPYK. This movement is likely compounded by high short interest and persistent investor caution regarding the company's widening net losses and the commercial timeline for its newly approved breast cancer treatment. The move appears to be company-specific, reflecting a consolidation of gains after recent regulatory milestones.

Celcuity  ·  Updated Sep 4

Rush Enterprises is moving significantly today following the announcement that it has completed its strategic joint venture with MCT Companies, a major Carrier Transicold dealer, to expand its commercial vehicle dealership network. This development follows the company's recent 3-for-2 stock split and the declaration of a quarterly cash dividend, which have bolstered investor sentiment. The upward price action appears to be company-specific, driven by these strategic growth initiatives and capital return milestones.

Rush Enterprises B  ·  Updated Sep 4

Arcosa stockholders approved CRH’s planned acquisition of 100% of the company in an all-cash deal valued at $150 per share. The transaction is expected to close in Q1 2027, pending regulatory approvals and other customary conditions.

CRH plc  ·  Updated Sep 4